Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Orchid Pharma Limited
Location
T. Score
Peers
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

ORCHID PHARMA LIMITED

Active

Updated: 22 Oct 2024

The company is a pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products

Orchid Pharma Limited, is a listed public company incorporated on 01 July, 1992. It is classified as a public limited company and is located in Kanchipuram, Tamil Nadu. It's authorized share capital is INR 150.00 cr and the total paid-up capital is INR 50.72 cr.

Industry

Manufacturing of Pharmaceuticals

Products

injectable cephalosporins, anti-diabetic, veterinary products, and non-antibiotics; and formulations comprising cardiovascular, oral cephalosporins, neuropsychiatry

Key Metrics

** All rupee values in INR crores. Based on March 2023 numbers.

Total Revenue

21.09%

₹ GET PRO

EBITDA

46.03%

₹ GET PRO

Net Profit

₹ GET PRO

Networth

7.97%

₹ GET PRO

Borrowings

23.66%

₹ GET PRO

Assets

11.8%

₹ GET PRO

Gross Margin

-1.37

GET PRO %

Operating Margin

2.28

GET PRO %

Net Profit Margin

8.7

GET PRO %

Return on Equity

8.11

GET PRO %

ROCE

7.29

GET PRO %

Debt to Equity

0.05

GET PRO

Sales

Mar 2023

Net worth

Mar 2023

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (9)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Peers / Similar Companies

Shilpa Medicare Limited Karnataka

Vital Laboratories Private Limited Maharashtra

Centaur Pharmaceuticals Private Limited Maharashtra

Malladi Drugs And Pharmaceuticals Limited Tamil Nadu

Reckitt Benckiser Healthcare India Private Limited Haryana

Pure And Cure Healthcare Private Limited Delhi

Tirupati Medicare Limited Delhi

Yashoda Healthcare Services Private Limited Telangana

Peers

Shilpa Medicare Limited

Karnataka

Vital Laboratories Private Limited

Maharashtra

Centaur Pharmaceuticals Private Limited

Maharashtra

Malladi Drugs And Pharmaceuticals Limited

Tamil Nadu

Reckitt Benckiser Healthcare India Private Limited

Haryana

Pure And Cure Healthcare Private Limited

Delhi

Tirupati Medicare Limited

Delhi

Yashoda Healthcare Services Private Limited

Telangana

Financial Highlights

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	89.0	40.8	40.8	40.8	40.8
Reserves	-793.0	983.5	612.1	606.6	647.8
Borrowings +	2,120.1	501.5	430.3	268.0	331.3
Long term borrowings	1,424.6	501.5	427.5	208.2	148.8
Short term borrowings	695.5	-	2.8	59.8	182.5
Trade payables +	302.4	103.4	110.0	167.7	181.8
Days payable	381.0	155.0	176.0	195.0	173.0
Other liabilities +	1,661.0	195.8	154.0	195.2	205.2
Other non-current liabilities	13.1	15.0	14.8	14.2	15.8
Other current liabilities	1,345.4	77.4	29.3	13.3	7.6
Total liabilities	3,077.0	1,721.7	1,237.3	1,110.6	1,225.2
Fixed Assets +	1,534.4	1,127.4	677.9	593.5	619.6
Tangible assets	1,140.6	1,020.8	670.1	583.4	572.7
CWIP	278.2	88.5	7.4	9.8	46.5
Intangible assets	115.7	18.1	0.4	0.3	0.4
LT loans and advances	-	-	-	-	-
Other non-current assets	845.0	7.0	130.4	80.5	104.6
Current assets +	697.7	587.2	429.0	436.6	501.0
Inventories	169.8	155.7	152.9	172.7	228.7
Trade receivables	119.9	68.0	135.7	170.6	215.2
Cash and cash equivalents	92.3	89.9	15.7	4.3	22.6
ST loans and advances	-	-	-	-	-
Other current assets	315.7	273.6	124.7	89.1	34.5
Total assets	3,077.0	1,721.7	1,237.3	1,110.6	1,225.2

Percentage of assets	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	2.89	2.37	3.3	3.68	3.33
Reserves	-25.77	57.13	49.47	54.62	52.88
Borrowings +	68.9	29.13	34.78	24.13	27.04
Long term borrowings	46.3	29.13	34.55	18.74	12.15
Short term borrowings	22.6	0.0	0.23	5.38	14.9
Trade payables	9.83	6.01	8.89	15.1	14.84
Other liabilities +	53.98	11.37	12.45	17.58	16.75
Other non-current liabilities	0.43	0.87	1.19	1.28	1.29
Other current liabilities	43.72	4.49	2.37	1.2	0.62
Total liabilities
Fixed Assets +	49.87	65.48	54.79	53.44	50.57
Tangible assets	37.07	59.29	54.16	52.53	46.74
CWIP	9.04	5.14	0.6	0.88	3.79
Intangible assets	3.76	1.05	0.03	0.03	0.03
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	27.46	0.41	10.54	7.25	8.54
Current assets +	22.67	34.11	34.67	39.31	40.89
Inventories	5.52	9.04	12.36	15.55	18.67
Trade receivables	3.9	3.95	10.97	15.36	17.56
Cash and cash equivalents	3.0	5.22	1.27	0.39	1.84
ST loans and advances	0.0	0.0	0.0	0.0	0.0
Other current assets	10.26	15.89	10.08	8.02	2.81
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales +	600.0	508.0	450.1	559.6	665.9
Sales growth %	-12.77	-15.32	-11.41	24.33	19.0
Expenses +	748.4	663.6	560.5	625.5	669.3
Cost of goods	289.7	243.3	228.5	313.6	384.6
Employee cost	82.3	84.7	68.1	63.3	68.2
Other costs	246.2	205.5	103.6	129.6	129.4
Operating profit +	-18.2	-25.5	49.8	53.1	83.6
Operating margin %	-3.0	-5.0	11.1	9.5	12.6
Other income	16.9	24.5	15.2	9.0	19.4
Interest	0.3	4.2	51.3	32.0	32.2
Depreciation	129.9	125.9	108.9	87.0	54.8
Exceptional items	200.9	-	-	-	39.2
Profit before tax	69.4	-131.1	-95.2	-56.9	55.2
Tax	-	-	-	-	-
Profit - disc. ops	-	-	-21.3	58.5	-6.8
Net profit	69.4	-131.1	-116.5	-2.0	46.3
Net margin %	11.2	-24.6	-26.2	-0.3	6.8

Precentage of total income	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	97.26	95.4	96.73	98.42	97.16
Expenses +	121.32	124.61	120.47	110.01	97.66
Cost of goods	46.96	45.68	49.11	55.15	56.12
Employee cost	13.34	15.91	14.64	11.13	9.96
Other costs	39.91	38.59	22.28	22.79	18.89
Operating profit	-2.95	-4.78	10.7	9.35	12.2
Other income	2.74	4.6	3.27	1.58	2.84
Interest	0.05	0.78	11.03	5.63	4.7
Depreciation	21.06	23.65	23.41	15.31	7.99
Exceptional items	32.57	0.0	0.0	0.0	5.72
Profit before tax	11.25	-24.61	-20.47	-10.01	8.06
Tax	0.0	0.0	0.0	0.0	0.0
Profit - disc. ops	0.0	0.0	-4.57	10.28	-0.99
Net profit	11.25	-24.61	-25.04	-0.34	6.76

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Solvency +
Total Debt/Equity	-3.0	0.5	0.7	0.4	0.5
Net Debt/Equity	-2.9	0.4	0.6	0.4	0.5
Total Debt/Assets	0.7	0.3	0.3	0.2	0.3
Total Assets/Equity	-4.4	1.7	1.9	1.7	1.8
Liquidity +
Current Ratio	0.3	3.2	3.0	1.8	1.4
Quick Ratio	0.2	2.4	1.9	1.1	0.7
Interest Coverage	-60.8	-6.1	1.0	1.7	2.6
Performance
Gross Margin	51.7	52.1	49.2	44.0	42.2
Operating Margin	-3.0	-5.0	11.1	9.5	12.6
Net Margin	11.2	-24.6	-26.2	-0.3	6.8
Return +
Return on Equity	-	-12.8	-17.9	-0.3	6.7
Pre-tax ROCE	133.1	-9.9	-6.1	-4.3	3.9
Return on Assets	2.3	-7.6	-9.4	-0.2	3.8
Pre-tax ROIC	-11.2	-10.5	-5.5	-3.7	2.9
Efficiency +
Days Payable	381.0	155.0	176.0	195.0	173.0
Days Inventory	214.0	234.0	244.0	201.0	217.0
Days Receivable	73.0	49.0	110.0	111.0	118.0
Fixed Asset Turnover	0.4	0.5	0.7	0.9	1.1
Total Asset Turnover	0.2	0.3	0.4	0.5	0.5
Working Capital
Cash Conversion Cycle	-94.0	128.0	178.0	117.0	162.0
Working Capital Days	-1,001.0	292.0	233.0	128.0	71.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

HDFC Bank Limited

No. of Loans: 1

Total Amount : 149.0 cr

Yes Bank Limited

No. of Loans: 1

Total Amount : 75.0 cr

Charge Holder	Amount	Date of creation/modification
HDFC Bank Limited	149.0 cr	10 Jan, 2024
Yes Bank Limited	75.0 cr	10 Jan, 2024

Charges

HDFC Bank Limited

Yes Bank Limited

People

Designation	Name	DIN/PAN	Tenure
Whole-time Director	Mridul Dhanuka	00199441	5 years
Managing Director	Manish Dhanuka	00238798	5 years
Director	Arjun Dhanuka	00454689	2 years
Director	Ram Gopal Agarwal	00627386	5 years
CFO	Sunil Kumar Gupta	<HIDDEN>	5 years
Director	Manoj Kumar Goyal	06361663	5 years
Director	Shubha Singh	06926872	1 years
Director	Dharam Vir	08771224	5 years
Director	Tanu Singla	08774132	5 years
Kmp	Kapil Dayya	<HIDDEN>	1 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
NORTHERN MINERALS LIMITED	Amalgamated	7.2 Cr	2	Delhi
M D BUILDTECH PRIVATE LIMITED	Active	1.4 L	1	Delhi
DHANUKA INFOTECH PRIVATE LIMITED	Strike Off	1.0 L	1	Delhi
DHANUKA CHEMICALS PRIVATE LIMITED	Active	1.0 L	1	Delhi
ORCHID BIO-PHARMA LIMITED	Active	15.0 Cr	5	Tamil Nadu
DHANUKA LABORATORIES LIMITED	Active	13.8 Cr	3	Tamil Nadu
ORBION PHARMACEUTICALS PRIVATE LIMITED	Active	175.0 Cr	1	Tamil Nadu
COSMO COMPONENTS PRIVATE LIMITED	Amalgamated	25.0 L	1	Delhi
DHANUKA AGRITECH LIMITED	Active	9.1 Cr	2	Delhi
DUKE IMPEX PRIVATE LIMITED	Amalgamated	25.0 L	1	Delhi
A.M. BROS. FINTRADE PRIVATE LIMITED	Amalgamated	1.0 Cr	1	Delhi
DHANUKA PHARMACEUTICALS PRIVATE LIMITED	Amalgamated	1.0 L	1	Tamil Nadu
SYNMEDIC LABORATORIES PRIVATE LIMITED	Active	1.0 L	1	Delhi
OTSUKA CHEMICAL (INDIA) PRIVATE LIMITED	Active	45.8 Cr	1	Delhi
DHANUKA AGRITECH LIMITED	Active	9.1 Cr	2	Delhi
LIBERTY SALES PRIVATE LIMITED	Amalgamated	25.0 L	1	Delhi
H D REALTORS PRIVATE LIMITED	Active	1.2 L	1	Delhi
DHANUKA FINVEST PRIVATE LIMITED	Amalgamated	1.0 Cr	1	Delhi
AETHER CONSULTING PRIVATE LIMITED	Active	1.0 L	1	Delhi
LORDS CHLORO ALKALI LIMITED	Active	25.2 Cr	1	Rajasthan
AMD INDUSTRIES LIMITED	Active	19.2 Cr	1	Delhi
UJALA HEALTHCARE SERVICES LIMITED	Active	10.0 Cr	1	Delhi
NOMENCLATURE ENGINEERING PRIVATE LIMITED	Active	1.0 L	1	Delhi
APTIA GROUP INDIA PRIVATE LIMITED	Active	85.0 Cr	1	Haryana

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
O r c h i d Pharmaceuticals Inc And Subsidiaries, USA	Usa	-	-
B e x e l Pharmaceuticals Inc., USA	United States	-	-
O r c h i d Pharmaceuticals SA (Proprietary) Limited, South Africa	South Africa	-	-
Di a k r o n Pharmaceuticals Inc., USA	United States	-	-
ORCHID BIO-PHARMA LIMITED	Tamil Nadu	2022	₹ 15.0 Cr
Orchid Pharmaceuticals Inc.	United States Of America	-	-
Bexel Pharmaceuticals Inc.	United State Of America	-	-
Orchid Pharmaceuticals SA (Proprietary) Limited	South Africa	-	-
Diakron Pharmaceuticals Inc.	United State Of America	-	-

Registered Details

CIN

L24222TN1992PLC022994

PAN

AAACO0402B

Incorporation

1992, 32.9 years

Company Email

cs@orchidpharma.com

Paid up Capital

₹ 50.7 Cr

Authorised Capital

₹ 150.0 Cr

AGM

Aug 2024

Type

Public

Non-government Company

FAQ - ORCHID PHARMA LIMITED

What is the incorporation date of ORCHID PHARMA LIMITED?

The incorporation date of ORCHID PHARMA LIMITED is 01 July, 1992

What is the authorized share capital of ORCHID PHARMA LIMITED?

The authorized share capital of ORCHID PHARMA LIMITED is INR ₹ 150.0 Cr.

What is the paid-up capital of ORCHID PHARMA LIMITED?

The paid-up capital of ORCHID PHARMA LIMITED is INR ₹ 50.7 Cr.

What is the registered address of ORCHID PHARMA LIMITED?

The registered address of ORCHID PHARMA LIMITED is PLOT NO 121-128, 128A-133, 138-151, 159-164 SIDCO INDUSTRIAL ESTATE,ALATHUR,CHENGALPATTU Alathur Ind Chengalpattu Kanchipuram Tamil Nadu - 603110

What is the CIN number of ORCHID PHARMA LIMITED?

The CIN number of ORCHID PHARMA LIMITED is L24222TN1992PLC022994.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

ORCHID PHARMA LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Peers / Similar Companies

Peers

Shilpa Medicare Limited

Vital Laboratories Private Limited

Centaur Pharmaceuticals Private Limited

Malladi Drugs And Pharmaceuticals Limited

Reckitt Benckiser Healthcare India Private Limited

Pure And Cure Healthcare Private Limited

Tirupati Medicare Limited

Yashoda Healthcare Services Private Limited

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network